INDSWFTLAB

Ind-Swift Laboratories Ltd.

330.20-6.5 (-1.95%)
19 Nov, 12:00 AM

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBoxTMWhat is StyleBox?

Neutral

This stock could not be classified into any of the StyleBoxes and hence a neutral stance.

Detail >
QVM scoreWhat is QVM score?

42.7 / 100

The stock has moderate QVM score relative to other stocks in the market. Neutral.

Analyst ratingWhat is Analyst rating?
No active sell-side coverage. Recommendations not available.
Technical indicatorsSee all >

17 %

Ind-Swift Laboratories Ltd. on 1D timeframe is bullish for 4 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

2025
Nov 30
2025
Dec 31
2026
Jan 31
2026
Feb 28
2026
Mar 31
2026
Apr 30
2026
May 31
2026
Jun 30
2026
Jul 31
2026
Aug 31
2026
Sept 30
2026
Oct 31
2026
Nov 21
Multiples
P/E (TTM)
2.692.443.134.584.144.344.8042.8447.0955.3558.6337.5033.70
P/B (latest)
0.550.500.640.960.870.911.011.281.412.292.432.171.95
P/S (TTM)
0.870.791.011.311.181.241.372.763.044.775.064.123.70
CAPE (3Y)
2.602.353.034.003.623.784.325.496.059.8210.4010.018.99
CAPE (5Y)
4.273.874.976.425.806.076.768.559.4215.3416.2515.4613.90
P/E (1Y Forward)
-------------
P/S (1Y Forward)
-------------
Yields (%)
Book to Market
1.832.021.571.041.151.090.990.780.710.440.410.460.51
Earnings yield
37.14%41.04%31.92%21.85%24.15%23.06%20.85%2.33%2.12%1.81%1.71%2.67%2.97%
Operating CF yield
-8.45%-9.34%-7.26%-3.16%-3.50%-3.34%-3.02%-4.26%-1.02%-0.63%-0.59%-1.63%-1.82%
FCFE yield
-8.52%-9.41%-7.32%-4.84%-5.35%-5.11%-2.53%-10.00%-6.23%-3.83%-3.61%-3.80%-4.23%
FCFF yield
-20.21%-26.03%-14.59%-7.25%-8.44%-7.86%-6.77%-12.11%-6.90%-3.80%-3.56%-2.40%-2.60%

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance
NIFTY50
NIFTYPHARMA
Add benchmark
Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary
INDSWFTLABNIFTY50NIFTYPHARMA
Start Period01 Jan 202101 Jan 202101 Jan 2021
End Period19 Nov 202619 Nov 202619 Nov 2026
Cumulative Return405.28%82.0%118.21%
CAGR31.74%10.73%14.2%
Volatility (ann.)54.61%14.15%15.56%
Max Drawdown -60.32%-17.23%-21.71%
RoMaD 0.53%0.62%0.65%
Sharpe0.710.530.69
Sortino1.170.741.01
Sortino/√20.830.530.72

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score

47.6 / 100

–

Ind-Swift Laboratories Ltd. is reasonably valued relative to other stocks in the market

What is Value score?
Momentum score

92.9 / 100

↑

Ind-Swift Laboratories Ltd. has high momentum relative to other stocks in the market

What is Momentum score?
Quality score

5.6 / 100

↓

Ind-Swift Laboratories Ltd. has low quality relative to other stocks in the market

What is Quality score?
QVM score

42.7 / 100

–

Ind-Swift Laboratories Ltd. has moderate QVM score with respect to other stocks in the market

What is QVM score?

A comprehensive scorecard to compare Ind-Swift Laboratories Ltd. on all metrics with other stocks. Access both rank and scores.

Value
Market
(All Stocks in NSE)
Sector
(Healthcare)
Industry Group
(Pharmaceuticals & Biotechnology)
Industry
(Pharmaceuticals)
Size and Listing
Days since Listing
9,017.00
Enterprise value
3,980 Cr
Market Cap
2,871 Cr
Liquidity
Avg daily turnover 1M
31 Cr
Avg daily volume 1M
8,38,897
Avg daily turnover 3M
32 Cr
Avg daily volume 3M
8,49,942
Bid Ask Spread
5.24%
Delivery Percentage
49.35%
Volume surge ratio
1.02
Ownership
DII Holding %
0.00%
QoQ change DII holding %
0.00%
FII Holding %
10.78%
QoQ change FII holding %
0.08%
QoQ change Gov holding %
0.00%
Promoter holding %
42.93%
QoQ change Promoter holding %
0.00%
Promoter pledged %
0.00%
Retail Holding %
39.85%
QoQ change Retail holding %
0.77%

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans
Benjamin Graham's Value
Piotroski F-Score
Dreman contrarian value
Peter Lynch Growth/Value
O'Shaugnessy Value
Templeton Growth/Value
Warren Buffet’s Consistent Compounders
John Neff’s contrarian value
Richard Driehaus Momentum Strategy
O'Shaughnessy Tiny Titans
1
Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

60.0 / 100

Ind-Swift Laboratories Ltd. passes 3 out of 5 of this checklist's rules
Hits
Misses

Frequently Asked Questions

What is the PB ratio of Ind-Swift Laboratories Ltd.?
The Price-to-Book (PB) ratio of Ind-Swift Laboratories Ltd. is 1.95. It compares the stock's market price to its book value per share.
What is the EV/EBITDA of Ind-Swift Laboratories Ltd.?
The EV/EBITDA of Ind-Swift Laboratories Ltd. is 33.01. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.
What is the debt-to-equity ratio of Ind-Swift Laboratories Ltd.?
The debt-to-equity (D/E) ratio of Ind-Swift Laboratories Ltd. is 1.04. The interest coverage ratio stands at 10.31x, reflecting the company's capacity to service its debt from operating earnings. A lower D/E ratio generally indicates a more financially stable company with less leverage.
What is the promoter holding in Ind-Swift Laboratories Ltd.?
Promoters hold 42.93% of Ind-Swift Laboratories Ltd. shares as per the latest quarterly shareholding disclosure.
What is the operating profit margin of Ind-Swift Laboratories Ltd.?
The operating profit margin of Ind-Swift Laboratories Ltd. is 2.26%, reflecting how much profit the company earns from its core operations relative to revenue.
What is the net profit margin of Ind-Swift Laboratories Ltd.?
The net profit margin of Ind-Swift Laboratories Ltd. is 10.98%, indicating the percentage of revenue that remains as profit after all expenses.
What is the Sharpely score for Ind-Swift Laboratories Ltd.?
On Sharpely's proprietary scoring system, Ind-Swift Laboratories Ltd. has a Quality Score of 5.6/100, Value Score of 48.6/100 and Price Momentum Score of 92.6/100, with an overall QVM Score of 42.7/100. The quality rating is low, value is moderate and price momentum is high. Visit the Scorecard and Checklist sections on the Analysis tab for a full breakdown.